Sonic Healthcare (STU:SAB) FFO


STU:SAB Sonic Healthcare Ltd STU:SAB
68 GF Score
Price €12.38
GF Value €20.03
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare FFO?

FFO (Funds from operations) only applies to REITs.

STU:SAB
68GF Score
Sonic Healthcare Ltd STU:SAB
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sonic Healthcare (STU:SAB) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of €12.38 is trading 38.2% below its estimated GF Value™ of €20.03. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for STU:SAB:

  • FFO:
  • GF Value™: €20.03 vs. price of €12.38 (38.2% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the STU:SAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
68GF Score

Get the complete analysis for STU:SAB

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.38
Price
€20.03
GF Value